Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-29

Clinical Trial Update: Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy

View source ↗

Summary

Expanded access IND for Hope Biosciences' autologous adipose-derived mesenchymal stem cells to treat cerebral palsy is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells (autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Cerebral Palsy | Status: NO_LONGER_AVAILABLE